Expired or temperature-damaged injectable medications may also result in unexpected side effects, such as irritation at the injection site
The peptide does not bind to a single identified receptor but instead modulates several biological systems simultaneously
The evidence for midlife women is growing A 2025 review in Current Opinion in Obstetrics and Gynecology concluded that GLP1 receptor agonists are among the most effective medications for weight loss and may be valuable for peri- and postmenopausal women, while noting that more population-specific data are needed
Funding This work was supported by grants from the Natural Science Foundation of Guangdong Province (2018A030313846 and 2021A1515012593), the Science and Technology Planning Project of Guangdong Province (2019A030317020), the National Natural Science Foundation of China (81802257, 81871859, 81772457, 82172750, 82172811, and 82260546), the Guangdong Basic and Applied Basic Research Foundation (GuangdongGuangzhou Joint Funds) (2022A1515111212), and the Science and Technology Program of Guangzhou (2023A04J1257)
doi:10.2147/CMAR.S205988
Read the complete article that reviews the changes in semaglutide side effect prevalences in California hospitals associated with increased use of Ozempic and Wegovy: here.
